V. Grando-Lemaire

发表

Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors

V. de Lédinghen, J. Zucman‐Rossi, T. Asselah, 2022, JHEP reports : innovation in hepatology.

A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosis.

D. Pessayre, R. Moreau, P. Nahon, 2012, Journal of hepatology.

Peripheral intrahepatic cholangiocarcinoma occurring in patients without cirrhosis or chronic bile duct diseases: epidemiology and histopathology of distant nontumoral liver in 57 White patients

J. Tran van Nhieu, M. Ziol, V. Bourcier, 2013, European journal of gastroenterology & hepatology.

Effect of Long-term Propranolol Treatment on Hepatocellular Carcinoma Incidence in Patients with HCV-Associated Cirrhosis

E. Vicaut, V. Bourcier, D. Roulot, 2012, Cancer Prevention Research.

Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.

V. de Lédinghen, P. Marcellin, F. Carrat, 2014, Gastroenterology.

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.

V. de Lédinghen, P. Marcellin, F. Carrat, 2013, Journal of hepatology.

[Hepatitis C virus screening in drug users in an addiction out-patient unit].

D. Roulot, J. Trinchet, M. Beaugrand, 2002, Gastroenterologie clinique et biologique.

Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

V. de Lédinghen, J. Zucman‐Rossi, T. Asselah, 2022, Journal of Cannabis Research.

Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis

V. de Lédinghen, T. Asselah, D. Thabut, 2021, BMC Infectious Diseases.

Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis.

M. Ziol, E. Vicaut, E. Cosson, 2010, Journal of hepatology.

Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alpha and ribavirin.

S. Pol, N. Ganne-Carrié, J. Trinchet, 2007, World journal of gastroenterology.

Dynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinoma

M. Ziol, D. Olive, V. Bourcier, 2019, Oncoimmunology.

Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients

V. Bourcier, N. Ganne-Carrié, O. Seror, 2005, European journal of gastroenterology & hepatology.

Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis

M. Ziol, D. Pessayre, P. Nahon, 2009, Hepatology.

Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.

N. Ganne-Carrié, J. Trinchet, M. Beaugrand, 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients.

E. Vicaut, E. Cosson, V. Bourcier, 2011, The Journal of clinical endocrinology and metabolism.

Diagnostic de cirrhose

J. Trinchet, V. Grando-Lemaire, 2004 .

Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis

V. de Lédinghen, J. Zucman‐Rossi, M. Ronot, 2021, JHEP reports : innovation in hepatology.

[Diagnosis of cirrhosis].

J. Trinchet, V. Grando-Lemaire, 2004, Gastroentérologie Clinique et Biologique.

Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol‐related cirrhosis

M. Ziol, P. Nahon, N. Ganne-Carrié, 2008, Alimentary pharmacology & therapeutics.

Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire.

S. Chevret, J. Trinchet, M. Beaugrand, 1999, Journal of hepatology.

HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis

M. Ziol, E. Vicaut, D. Roulot, 2011, Journal of viral hepatitis.

Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis.

M. Ziol, E. Vicaut, E. Cosson, 2010, Journal of hepatology.

Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort)

V. de Lédinghen, J. Zucman‐Rossi, D. Thabut, 2023, Quality of Life Research.

[Percutaneous ablation of hepatocellular carcinoma].

N. Ganne-Carrié, O. Seror, J. Trinchet, 2003, Gastroenterologie clinique et biologique.